This review discusses the limitations of the current American Joint Committee on Cancer staging system for soft tissue sarcomas and the potential benefits of predictive nomograms.
AJCC staging may limit sarcoma prognostication; nomograms leave open refined prediction pending prospective validation.
Soft tissue sarcomas (STS) are a rare and heterogenous group of tumors that often represent a management challenge. The American Joint Committee on Cancer system is currently used to stage tumors and direct treatment. Limitations of the current STS staging system, future potential direction for pre-operative staging, as well as the benefit of predictive nomograms for filling current knowledge gaps are all discussed. J. Surg. Oncol. 2015 111:532-539. Published 2014. This article has been contributed to by US Government employees and their work is in the public domain in the USA.
No takes yet. Share an insight, caveat, or question.
Massarweh et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: